Matthew Onaitis

Director of Finance/CFO at MAINSTAY MEDICAL INTERNATIONAL

55 year

Health Technology

Consumer Services

Health Services

Profile

Matthew W.
Onaitis is currently Director at Snp Bio, Inc. and Stratify Genomics, Inc., and Chief Financial Officer at Mainstay Medical International Ltd. since 2018.
Formerly, Mr. Onaitis was Director-Legal Affairs at Elan Corp.
Plc (2004-2005), Associate General Counsel at Biogen, Inc. (2006), Secretary, Senior Vice President & General Counsel at Somaxon Pharmaceuticals, Inc. (2010-2013), Secretary & General Counsel at Trius Therapeutics, Inc. (2013), Secretary & General Counsel at Ignyta, Inc. (2014-2016), and CFO, Secretary, CAO & General Counsel at Cidara Therapeutics, Inc. (2016-2018).
Education includes an undergraduate degree from Carnegie Mellon University (1993) and a graduate degree from Stanford Law School (1998).

Matthew Onaitis active positions

Companies	Position	Start
MAINSTAY MEDICAL INTERNATIONAL	Director of Finance/CFO	2018-08-19
Snp Bio, Inc.	Director/Board Member	-
Stratify Genomics, Inc. Stratify Genomics, Inc. Medical/Nursing ServicesHealth Services Operates as a cancer risk stratification company	Director/Board Member	-

All active positions of Matthew Onaitis

Former positions of Matthew Onaitis

Companies	Position	End
CIDARA THERAPEUTICS	Director of Finance/CFO	2018-08-16
IGNYTA INC	General Counsel	2016-05-31
Trius Therapeutics, Inc. Trius Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops antibacterial drugs for the treatment of infections	General Counsel	2013-11-30
Somaxon Pharmaceuticals, Inc. Somaxon Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes pharmaceutical products	General Counsel	2013-02-28
BIOGEN INC.	Corporate Officer/Principal	2006-04-30

See the detail of Matthew Onaitis's experience

Training of Matthew Onaitis

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Matthew Onaitis's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	11
Elan Corp. Plc Elan Corp. Plc Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals and drug delivery systems	Health Technology
Biogen, Inc. Biogen, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets therapies for neurological and neurodegenerative diseases	Health Technology
Carnegie Mellon University Carnegie Mellon University Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Somaxon Pharmaceuticals, Inc. Somaxon Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes pharmaceutical products	Health Technology
Mainstay Medical International Ltd. Mainstay Medical International Ltd. Medical SpecialtiesHealth Technology Develops neurostimulation therapies for people with chronic mechanical low back pain	Health Technology
Trius Therapeutics, Inc. Trius Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops antibacterial drugs for the treatment of infections	Health Technology
Ignyta, Inc. Ignyta, Inc. BiotechnologyHealth Technology Operates as a medicine biotechnology company which provides new drugs services for cancer patients	Health Technology
Stanford Law School Stanford Law School Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Cidara Therapeutics, Inc. Cidara Therapeutics, Inc. Pharmaceuticals: OtherHealth Technology Engages in the discovery, development, and commercialization of novel anti-infectives	Health Technology
Snp Bio, Inc.
Stratify Genomics, Inc. Stratify Genomics, Inc. Medical/Nursing ServicesHealth Services Operates as a cancer risk stratification company	Health Services